Blog
-
LNP-mediated mRNA delivery in human PBMC: T cell-targeted transfection
Published : 09/24/2026Application note: transfection efficiency, cell-type tropism and viability of a new ionizable lipid LNP formulation in human PBMCs, with focus on T cells.
-
Stem cell mRNA transfection: LNP delivery Application Note
Published : 06/25/2026Evaluate NanOZ-LNP Stem for efficient mRNA delivery to primary human CD34+ stem cells. Data on transfection efficiency, viability, and phenotype preservation.
-
White paper: Ionizable lipids for mRNA-LNP and siRNA-LNP delivery
Published : 04/07/2026This white paper examines the development of Lipid Nanoparticles (LNP) formulations for mRNA and siRNA delivery, focusing on innovations at OZ Biosciences.
-
New partnership with ExploRNA Therapeutics to strengthen our mRNA platform
Published : 02/03/2026This partnership marks an important milestone in strengthening our RNA platform and expanding high-performance solutions for the mRNA community.
-
New high-expression Cytokine mRNAs for research
Published : 12/24/2025We’re pleased to introduce five new Cytokine mRNAs to our portfolio: IFNα, IFNγ, TGFα, TGFβ & TNFα.
-
New ready-to-use LNP-siRNA for efficient gene silencing
Published : 11/19/2025Designed based on our expertise in lipid nanoparticle engineering, these ready-to-use LNPs ensure siRNA protection, enhanced intracellular uptake, and robust knockdown efficacy.
-
Why choose mRNAs over pDNA?
Published : 09/24/2025Discover why mRNA is safer and more efficient than plasmid DNA: faster protein expression, no genomic integration, and promoter-independent benefits.
-
Lipid Nanoparticles (LNPs): A complete guide for researchers
Published : 08/21/2025Lipid nanoparticles (LNPs) have become essential tools in nucleic acid delivery, gene therapy, and mRNA vaccines. This guide covers their production and experimental performance.